blindness with glp 1 sudden Recent studies have begun to explore a possible link between GLP-1 GLP-1 meds and vision: what

GLP-1 receptor agonists exert neuroprotective effects primarily by inhibiting microglial activation, the primary effector cells of neuroinflammation, thus reducing the production of proinflammatory cytokines (e.g., TNF- , IL-1) and alleviating inflammatory damage to brain parenchyma

Effective treatment of obesity could have far-reaching consequences that extend beyond just weight management, affecting metabolic parameters such as heart disease and even cancer

Overcoming endocrine resistance in metastatic breast cancer: current evidence and future directions

During the medication process, patients should strictly follow the doctor's instructions and should not change the medication plan arbitrarily

doi: 10.1073/pnas.042692199 198 Lo-Thong-ViramoutouO.ChartonP.CadetX